RESMED INC — Director's Dealing 2024

Nov 24, 2024

FORM 4

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL
OMB Number:	3235-0287
Estimated average burden

hours per response: 0.5

1. Name and Address of Reporting Person*Karen, Drexler	2. Issuer Name and Ticker or Trading SymbolRESMED INC [RMD ]	5. Relationship of Reporting Person(s) to Issuer(Check all applicable)
(Last)(First)(Middle)9001 Spectrum Center Blvdc/o ResMed Inc	3. Date of Earliest Transaction (Month/Day/Year)11/20/2024	XDirector10% OwnerOfficer (give title below)Other (specify below)
(Street)San DiegoCA92123(City)(State)(Zip)	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line)Form filed by One Reporting PersonXForm filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date(Month/Day/Year)	2A. Deemed ExecutionDate, if any(Month/Day/Year)	3. TransactionCode(Instr. 8)		4. Securities Acquired (A) orDisposed of (D)(Instr. 3, 4, and 5)			5. Amount of Securities BeneficiallyOwned Following ReportedTransaction(s)(Instr. 3 and 4)	6. Ownership Form:Direct(D) or Indirect (I)(Instr. 4)	7. Nature of IndirectBeneficial Ownership(Instr. 4)
			Code	V	Amount	(A)or(D)	Price
ResMed Common Stock	11/20/2024		A (1)		1,083	A	$0	9,529	D

	Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned(e.g., puts, calls, warrants, options, convertible securities)
1. Title ofDerivativeSecurity(Instr.3)	2. Conversionor ExercisePrice ofDerivativeSecurity	3. Transaction Date(Month/Day/Year)	3A. DeemedExecution Date, ifany(Month/Day/Year)	4.TransactionCode(Instr. 8)		5. Number ofDerivativeSecuritiesAcquired (A) orDisposed of (D)(Instr. 3, 4 and 5)		6. Date Exercisable andExpiration Date(Month/Day/Year)		7. Title and Amount ofSecurities UnderlyingDerivative Security(Instr. 3 and 4)		8. Price ofDerivativeSecurity(Instr. 5)	9. Number ofDerivativeSecuritiesBeneficially OwnedFollowing ReportedTransaction(s)	10.OwnershipForm: Direct(D) orIndirect (I)(Instr. 4)	11. Nature ofIndirectBeneficialOwnership(Instr. 4)
				Code	V	(A)	(D)	DateExercisable	ExpirationDate	Title	AmountorNumberof Shares			(Instr. 4)

Explanation of Responses:

1. Shares awarded represent Restricted Stock Units. The RSUs cliff vest on the earlier of 11/11/2025, or the annual shareholder's meeting in the year following the grant date.

Karen Drexler, director 11/21/2024

** Signature of Reporting Person Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.